Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

Inside the deadly disease confounding medicine, researchers piecing together clues and the breakthrough that meant survival ...

For many years, it was believed that when an individual develops liver scarring, it can not be reversed. Today, we know that ...

A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

PHILADELPHIA, Pa. -- If you heard constant cheering and saw beaming smiles on the Benjamin Franklin Parkway this morning, you may have been in the presence of Emily's Entourage. It's a group of ...

CHARLESTON, S.C. (WCSC) - Hundreds of Lowcountry moms danced the night away all in support of research to support a treatment for a genetic disorder. The Charleston Mom Prom is a charity event hosted ...

CHICAGO, June 5, 2025 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF)'s, the nation's leading pulmonary fibrosis (PF) research, education, and advocacy organization, invites people living with ...

CHARLESTON, S.C. (WCIV) — The Cystic Fibrosis Foundation will be hosting a spooktacular circus bash full of tricks and treats this Friday, as the organization works to raise money to aid in finding a ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...

The investigators explained that GLP-1 receptor agonists appear to be able to help resolve MASH without worsening fibrosis. Those findings have been confirmed in mouse models and in multiple studies ...

Eftilagimod alfa and Keytruda with radiotherapy improved tumor hyalinization/fibrosis rates in resectable soft tissue sarcoma, surpassing the trial's primary endpoint. The combination therapy achieved ...